ArticleAmerican journal of hypertension2020

Empagliflozin for Patients With Presumed Resistant Hypertension: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial.

João Pedro Ferreira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.